Which companies are involved in this healthcare partnership?

The partnership involves three companies: SMBC Group, Fujitsu Limited, and SoftBank Corp.

What is the main objective of this alliance?

The main objective is to build a domestic healthcare platform to make Japan's healthcare system sustainable by extending healthy life expectancy, improving the operational efficiency of medical institutions, and helping to control national medical expenses.

What will the new healthcare platform consist of?

It will consist of a data platform to securely manage and utilize medical data, and a user application featuring an AI agent that provides personalized health support by combining medical and personal health data with user consent.

What are the roles of each company in this partnership?

SMBC Group will focus on user acquisition and integrating financial services. Fujitsu will lead the development of the data platform and medical AI. SoftBank will lead the development of the user application, leveraging its large user base.

What are the long-term goals of this initiative?

The companies aim to expand the platform's user base to 60 million people, introduce it to 4,000 medical institutions, and contribute to curbing future medical cost increases by an estimated 5 trillion yen.

AI News NQ Analysis

SMBC集團、富士通與軟銀達成業務合作協議，將建構日本國產健康醫療平台以實現可持續發展的醫療服務

NQ 評分 95/100

AI 摘要（NQ 加工版）

SMBC集團、富士通與軟銀三方達成合作，將建立一個利用醫療與健康數據的日本國產健康醫療平台，旨在延長國民的健康壽命並抑制醫療費用。

AI 分析

常見問題

Q: Which companies are involved in this healthcare partnership?: A: The partnership involves three companies: SMBC Group, Fujitsu Limited, and SoftBank Corp.
Q: What is the main objective of this alliance?: A: The main objective is to build a domestic healthcare platform to make Japan's healthcare system sustainable by extending healthy life expectancy, improving the operational efficiency of medical institutions, and helping to control national medical expenses.
Q: What will the new healthcare platform consist of?: A: It will consist of a data platform to securely manage and utilize medical data, and a user application featuring an AI agent that provides personalized health support by combining medical and personal health data with user consent.
Q: What are the roles of each company in this partnership?: A: SMBC Group will focus on user acquisition and integrating financial services. Fujitsu will lead the development of the data platform and medical AI. SoftBank will lead the development of the user application, leveraging its large user base.
Q: What are the long-term goals of this initiative?: A: The companies aim to expand the platform's user base to 60 million people, introduce it to 4,000 medical institutions, and contribute to curbing future medical cost increases by an estimated 5 trillion yen.